Feb 3, 2024

Biotech is the new focus in U.S.-China tech rivalry

Posted by in categories: biotech/medical, economics, food, security

The need to quash outbreaks, quickly create medicines, stress-proof crops and fend off other 21st century threats is providing a lucrative arena for biotech companies to sell their services.

Why it matters: But the infrastructure to support such ambitions is increasingly recognized by the U.S., China and other countries as a linchpin of national security and economic strategy, putting it at the center of geopolitics.

Comments are closed.